Biopharma Financial Climate and Market Dynamics in 2023: Interview with David Dowling, Ropes & Gray
Recently, David Dowling, a senior lawyer at Ropes & Gray, has outlined his predictions for M&A in the European biotech …
All Posts
The Time for Breakthroughs in Antibiotic Discovery
Since a revolutionary discovery of penicillin in 1928 by Scottish bacteriologist and Nobel laureate Alexander Fleming, numerous inventions of new …
British Patient Capital Backs Notable Cancer Research with $7 million Investment in Grey Wolf Therapeutics
British Patient Capital, a subsidiary of the British Business Bank, invested $7 million in Grey Wolf Therapeutics, an Oxford-based biotech …
Unlocking the Proteome's Secrets: The Advancement of Single-Molecule Protein Sequencing Techniques
Even though characterizing the proteome, the complete set of proteins made by a cell or organism, can yield important insights …
Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung
Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …
2022 in Retrospect: 10 Breakthrough Technologies in Drug Discovery
Reflecting on 2022, let’s review several breakthrough technologies that are shaping the future of biology research and drug discovery. I …
15 Biopharma Research Trends to Watch in 2022
Table of contents: mRNA vaccines and RNA therapies Epitranscriptomics Targeting RNA with small molecules Deep learning and big data …
A Look at Longevity Industry: Interview with Dr. Eric Leire, CEO of Genflow Biosciences
The aging research industry has exploded in recent years. Once a fringe area of science, aging research has now gained …
Innovation and Sustainability Trends for 2023: Interview with Jesper Jonsson, Director of Medical Devices at Owen Mumford
The medical device industry is driven by constant innovation, and the annual Medica conference offers the chance to discover the …
14 Publicly Traded Companies Developing Longevity Therapeutics
The longevity industry has been growing throughout the past decades, attracting more attention to the healthy aging process and searching …
Choosing Cancer Weapons With the Best Aim
In oncology, we do the best we can. We give drugs with 10-20% chances of working because we have nothing …
MGI Tech Expands Sequencing Capabilities in Europe
In November, MGI Tech Co, a Shenzhen-based biotechnology company, an affiliated company of BGI Group, committed to building core tools and …